Bruker Co. (NASDAQ:BRKR – Free Report) – Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research report issued on Tuesday, March 11th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $2.68 for the year, up from their previous estimate of $2.67. The consensus estimate for Bruker’s current full-year earnings is $2.69 per share.
Bruker (NASDAQ:BRKR – Get Free Report) last issued its earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%.
Read Our Latest Research Report on BRKR
Bruker Trading Up 2.2 %
Shares of NASDAQ BRKR opened at $45.97 on Friday. The company has a market cap of $6.97 billion, a price-to-earnings ratio of 60.49, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. Bruker has a 12-month low of $44.11 and a 12-month high of $94.86. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The stock’s 50 day simple moving average is $53.66 and its 200 day simple moving average is $58.40.
Bruker Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date is Monday, March 17th. Bruker’s dividend payout ratio is presently 26.32%.
Institutional Trading of Bruker
Hedge funds and other institutional investors have recently modified their holdings of the company. True Wealth Design LLC raised its stake in shares of Bruker by 4,636.4% in the 3rd quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock worth $36,000 after buying an additional 510 shares in the last quarter. Eagle Bay Advisors LLC raised its stake in shares of Bruker by 2,324.1% in the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock worth $41,000 after buying an additional 674 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Bruker by 37.5% in the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after buying an additional 248 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Bruker by 18.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company’s stock worth $75,000 after buying an additional 196 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Bruker by 47.5% in the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock worth $75,000 after acquiring an additional 412 shares during the last quarter. Institutional investors own 79.52% of the company’s stock.
Bruker Company Profile
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Further Reading
- Five stocks we like better than Bruker
- Golden Cross Stocks: Pattern, Examples and Charts
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Do S&P 500 Stocks Tell Investors About the Market?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.